Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 14/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2327154 | 1.00 | KIF11 (0.52) | KIF11KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL2328040 | 1.00 | KIF11 (0.52) | KIF11KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL2328128 | 1.00 | KIF11 (0.52) | KIF11KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL2324748 | 1.00 | KIF11 (0.52) | KIF11KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL2326446 | 0.98 | KIF11 (0.53) | KIF11KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL2325018 | 0.92 | KIF11 (0.55) | KIF11KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL8516933 | 0.84 | KIF11 (0.55) | KIF11KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL31415572 | 0.84 | KIF11 (0.55) | KIF11KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL2326286 | 0.84 | KIF11 (0.48) | KIF11KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL8016473 | 0.77 | KIF11 (0.47) | KIF11KCNH2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1987881-B1 | METHOD FOR SEPARATION AND COLLECTION OF DIALKYL TIN DIALKOXIDE | ASAHI KASEI CHEMICALS CORP (JP) | 2011-08-17 | — | — | EP | disclosed |
| US-7842828-B2 | Method for separating out and recovering dialkyltin dialkoxide | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-11-30 | — | — | US | disclosed |
| US-20100160662-A1 | Method for Separating Out and Recovering Dialkyltin Dialkoxide | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2010-06-24 | — | — | US | disclosed |
| EP-1987881-A1 | METHOD FOR SEPARATION AND COLLECTION OF DIALKYL TIN DIALKOXIDE | Asahi Kasei Chemicals Corporation (JP) | 2008-11-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160662-A1 | Method for Separating Out and Recovering Dialkyltin Dialkoxide | ALOX5, ALOX15B, ALOX15 | KIF11 4761/4885KCNH2 1319/4885CYP3A4 796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.